News

Weed Week: Cannabis advent calendars and US Republicans introduce weed bill for veterans

Weed Week: Cannabis advent calendars and US Republicans introduce weed bill for veterans

Instead of a chocolate advent calendar this year, Californians can get their hands on a...

IHL’s psilocybin treatment takes 2 steps forward, with a boost from the FDA and ethics approval to commence trials at Monash University

IHL’s psilocybin treatment takes 2 steps forward, with a boost from the FDA and ethics approval to commence trials at Monash University

Special Report: The world-first treatment is on track to commence clinical trials in early 2022....

Incannex Healthcare moves forward with soft gel capsule design for IHL-42X to treat obstructive sleep apnoea

Incannex Healthcare moves forward with soft gel capsule design for IHL-42X to treat obstructive sleep apnoea

Special Report: Cannabinoid and psychedelic biotech company Incannex Healthcare (ASX: IHL) has engaged Colombian-based manufacturer...

ASX Health Stocks: Truscreen jumps 38% on business update, flagging strong growth in China

ASX Health Stocks: Truscreen jumps 38% on business update, flagging strong growth in China

The ASX 200 Health Index (XHJ) is up by 1.2% at the time of writing,...

Dr Boreham’s Crucible: 4 ASX stocks focused on a mind-altering $25 billion psilocybin market

Dr Boreham’s Crucible: 4 ASX stocks focused on a mind-altering $25 billion psilocybin market

With more than 120 trials in the last decade, and a potential $25 billon market,...

The TGA could soon relax rules on psychedelics. Here are the ASX stocks that could benefit

The TGA could soon relax rules on psychedelics. Here are the ASX stocks that could benefit

After decades of being stigmatised and shunned, psychedelic drugs are making a comeback. The Australian...

CBD Oil: The ultimate investor’s guide to a potential $64 billion global market

CBD Oil: The ultimate investor’s guide to a potential $64 billion global market

Cannabis has been used as medicine for thousands of years. Ancient Indian, Chinese, and Egyptian...

Check Up: Dimerix and ImpediMed announced breakthroughs, while earnings dominate news flow in August

Check Up: Dimerix and ImpediMed announced breakthroughs, while earnings dominate news flow in August

Although earnings results were the main theme in August, there were also some notable healthcare...

Weed Week: Cannabis trade shows and Europe imports medicinal marijuana

Weed Week: Cannabis trade shows and Europe imports medicinal marijuana

Virginia is the latest US state to legalise marijuana and they’re celebrating with the first...

Incannex sets sights on US capital markets and prepares for a Nasdaq listing

Incannex sets sights on US capital markets and prepares for a Nasdaq listing

Special Report: Incannex lodged extensive registration form with SEC. A strategic dual-listing will give Incannex...

ASX health stocks: CSL leads another round of strong earnings, but FY22 outlook remains subdued

ASX health stocks: CSL leads another round of strong earnings, but FY22 outlook remains subdued

The ASX 200 health stocks index (XHJ) fell by 0.76% this morning, compared to the...

Rise and Shine: What you need to know before the ASX opens

Rise and Shine: What you need to know before the ASX opens

On Stockhead today, the stock that has soared 10,000pc, all you need to know about...

Weed Week: Cannabis ice cream deal and Israeli CBD market worth US$475m by 2025

Weed Week: Cannabis ice cream deal and Israeli CBD market worth US$475m by 2025

Massachusetts based MariMed has just announced a joint collaboration with a legendary ice cream brand...

ASX health stocks: Rhinomed rockets 80% after securing first government purchase for COVID-19 Rhinoswabs

ASX health stocks: Rhinomed rockets 80% after securing first government purchase for COVID-19 Rhinoswabs

The ASX200 health stocks index (XHJ) fell by 0.13% this morning, compared to the broader...

IHL’s global research team lays out the blueprint for its psilocybin therapy development pathway, shares climb

IHL’s global research team lays out the blueprint for its psilocybin therapy development pathway, shares climb

Special Report: The company’s latest update clearly illustrates the rigorous testing approach adopted by IHL’s...

ASX health stocks: EMV’s brain scanner is completed and ready for testing, stock price jumps 16pc

ASX health stocks: EMV’s brain scanner is completed and ready for testing, stock price jumps 16pc

The ASX200 health stocks index (XHJ) fell by 0.14% this morning, compared to the broader...

Market Highlights and 5 ASX Small Caps to watch on Tuesday

Market Highlights and 5 ASX Small Caps to watch on Tuesday

Wall Street mixed as oil and metals fall US stock markets were mixed on Monday,...

A busy Q4 shows how Incannex Healthcare is laying the foundations for its clinically backed global growth strategy

A busy Q4 shows how Incannex Healthcare is laying the foundations for its clinically backed global growth strategy

Special Report: The June quarter demonstrated IHL’s ability to execute on a multi-channel development strategy....

Incannex kicks off Phase 1 clinical trial for its anti-inflammatory treatment

Incannex kicks off Phase 1 clinical trial for its anti-inflammatory treatment

Special Report: Along with Phase 1 trials for IHL-675A, the company also received a positive...

ASX health stocks: Proteomics jumps 10% on blood test deal with Nasdaq-listed Abcam

ASX health stocks: Proteomics jumps 10% on blood test deal with Nasdaq-listed Abcam

The ASX Healthcare index fell slightly by 0.17% this morning, compared with the broader index...

ASX health stocks: AusCann (ASX:AC8) up 5pc after asking for approval of cannabis-based canine drug

ASX health stocks: AusCann (ASX:AC8) up 5pc after asking for approval of cannabis-based canine drug

The ASX Healthcare index rose by 0.45% this morning, compared with the broader index which...

Incannex secures complete supply chain solution for its anti-inflammatory multi-use drug

Incannex secures complete supply chain solution for its anti-inflammatory multi-use drug

Special Report: Incannex has engaged Procaps to develop and manufacture its IHL-675A soft-gel capsules in...

Market highlights and 5 ASX small caps to watch on Friday

Market highlights and 5 ASX small caps to watch on Friday

Wall Street mixed as F45 makes US IPO debut There was no clear direction in...

Why this hidden gem in the Incannex product suite could be a global market winner

Why this hidden gem in the Incannex product suite could be a global market winner

Special Report: The company now has a targeted research pathway to clinical success, with strong...

Global pharma leader Vectura will help Incannex develop its concussion treatment drug

Global pharma leader Vectura will help Incannex develop its concussion treatment drug

Special Report: The deal gives IHL a global partner to develop the drug and navigate...

Market highlights and 5 ASX small caps to watch on Monday

Market highlights and 5 ASX small caps to watch on Monday

Wall Street plummets on ‘Triple Witching day’ All major US indices fell on Friday, mostly...

US growing approvals a ‘monumental’ step away from Trump moratorium on pot licensing

US growing approvals a ‘monumental’ step away from Trump moratorium on pot licensing

Last week the US government announced it would begin granting growing approvals to several companies...

Incannex takes key step towards FDA approval for IHL-42X with new research partnership

Incannex takes key step towards FDA approval for IHL-42X with new research partnership

Special Report: The company has partnered with one of Australia’s leading sleep science research as...

Market highlights and 5 ASX small caps to watch on Tuesday

Market highlights and 5 ASX small caps to watch on Tuesday

Tech stocks fell hard on the eve of US CPI report All major indices fell...

Incannex highlights Q1 momentum with 4C update, shares rally again

Incannex highlights Q1 momentum with 4C update, shares rally again

Special Report: The company is moving from strength to strength as it builds out its...

US banks closer to legally doing business with cannabis, as ASX-listed Incannex pushes its way into the country

US banks closer to legally doing business with cannabis, as ASX-listed Incannex pushes its way into the country

The US cannabis market reacted in jubilation last week, after the Secure and Fair Enforcement...

How Incannex is positioning to be the ‘next GW Pharma’, with CEO Joel Latham

How Incannex is positioning to be the ‘next GW Pharma’, with CEO Joel Latham

Special Report: Incannex provides investors the best of breed for medicinal cannabis and psychedelic therapy...

Hot Pot Stocks: Here are 8 ASX plays that have tripled in the last 12 months

Hot Pot Stocks: Here are 8 ASX plays that have tripled in the last 12 months

ASX pot stocks have run hot in recent months but eight in particular have been...

Weed Week: 4/20 can’t help ASX cannabis companies

Weed Week: 4/20 can’t help ASX cannabis companies

April 20 has come and gone, but ASX cannabis companies aren’t getting that high —...

Incannex gets more good news, as FDA approves expanded development pathway for its IHL-675 treatment

Incannex gets more good news, as FDA approves expanded development pathway for its IHL-675 treatment

Special Report: Incannex Healthcare (ASX:IHL) continues to execute on its multi-channel development pathway for clinically-proven...

Incannex granted meeting with FDA over CBD drug cocktail

Incannex granted meeting with FDA over CBD drug cocktail

Special Report: Incannex Healthcare (ASX:IHL) is making steady progress on its hydroxychloroquine (HCQ)/cannabidiol (CBD) drug...

1 in 10 COVID survivors in Britain still suffer symptoms; ASX cannabis stock Bod wants to help

1 in 10 COVID survivors in Britain still suffer symptoms; ASX cannabis stock Bod wants to help

Cannabis stock Bod Australia (ASX:BDA) has entered the fight against what is known as “long-COVID”....

Incannex will pursue a SIXTH possible use for its experimental drug cocktail: treating rheumatoid arthritis

Incannex will pursue a SIXTH possible use for its experimental drug cocktail: treating rheumatoid arthritis

Special Report: Incannex Healthcare (ASX:IHL) hydroxychloroquine/cannabidiol (CBD) cocktail is turning into a veritable wonder drug...

Rise and Shine: What you need to know before the ASX opens

Rise and Shine: What you need to know before the ASX opens

On Stockhead today, should nickel bulls be worried about Tsingshan’s big move, details of China’s five-year...

Rise and Shine: What you need to know before the ASX opens

Rise and Shine: What you need to know before the ASX opens

On Stockhead today, who’s going to solve WA’s gas problem, 10 stocks that went 20-bag after Covid,...

Incannex teams up with Monash University and the NFL in exciting new study for its proprietary concussion treatment

Incannex teams up with Monash University and the NFL in exciting new study for its proprietary concussion treatment

Special Report: The new study could accelerate the pathway to Phase 2 clinical trials for...

Market highlights and 5 ASX small caps to watch on Thursday

Market highlights and 5 ASX small caps to watch on Thursday

Wall Street rallied again Stocks on Wall Street rallied for the second day in a...

So, COVID vaccines are here; what now for all those biotechs working on COVID 19 drugs or tests?

So, COVID vaccines are here; what now for all those biotechs working on COVID 19 drugs or tests?

COVID-19 vaccines have reached Australia but ASX stocks that were making anti-COVID 19 drugs or...

Incannex says its experimental drug cocktail might work to treat inflammatory bowel disease

Incannex says its experimental drug cocktail might work to treat inflammatory bowel disease

Special Report: Incannex Healthcare (ASX:IHL) has found a fifth possible use for its hydroxychloroquine/cannabidiol (CBD)...

Rise and Shine: What you need to know before the ASX opens

Rise and Shine: What you need to know before the ASX opens

On Stockhead today, is Australia on top of this hydrogen thing, the most in-demand ASX stocks right...

Incannex shares jump as cannabis/psychedelic pharma company explores dual listing on NYSE or NASDAQ

Incannex shares jump as cannabis/psychedelic pharma company explores dual listing on NYSE or NASDAQ

Special Report: Incannex Healthcare (ASX:IHL) has announced it will explore a dual listing in the...

Incannex says it’s received results that its cannabinoid drug cocktail may work as an asthma treatment

Incannex says it’s received results that its cannabinoid drug cocktail may work as an asthma treatment

Special Report: Incannex Healthcare (ASX:IHL) shares have gained after the pharmaceutical development company announced it...

3 cannabis players discuss how to view the sector through a biotech lens

3 cannabis players discuss how to view the sector through a biotech lens

ASX cannabis stocks have gotten a boost from the rising tide of regulation in recent...

Subscribe

Stay up to date with Incannex’s research and development program.